Well a little more realistic as to our current financial situation or lack thereof. 

Certainly Zenith idea is an additional approach. Probably better for all if it was still one company. Increasing our chances of success. Maybe the ex- Goldman guy is ready to take on royalty interest if he has been so successful as indicated. 

It is encouraging that a lot of high revenue drugs are coming off patent that was interesting to see. In theory in makes sense that maybe just maybe Epigenetics will be adopted by the Pharmas fairly soon out of necessity. 

Not sure I follow how we have no competition. Will have to fact check that.

I found it curious that CSO was available to take questions but was not coming up to speak comment. It sure would help if we could here from a scientist as well.

Also the comment of pharmas with lots of cash but no science sounds like the polar opposite of us. 

It would not take much for our share price to advance given that we have probably one of the biggest drops in share price as per his reasoning on the state of the life science space. 

I remain cautiously optimistic given that Don situation more closely reflects the reality of his situation.